A. Blauvelt, “Secukinumab Provides Complete or Almost-Complete Psoriasis Clearance in Moderate-to-Severe Plaque Psoriasis: Pooled Analysis of 4 Phase 3 Trials”, J of Skin, vol. 2, no. S1, p. S19, Feb. 2018.